 For this clinical trial, there are two treatment groups, i.e., investigational patients who receive the MAVERICKTM Total Disc Replacement and control patients who receive the anterior lumbar interbody fusion procedure with INFUSE Bone GraftLT-CAGE Lumbar Tapered Fusion Device. Each investigational site will enroll patients in a 2:1 investigational:control treatment randomization scheme. 